AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 71 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,485 | +7.3% | 29,822 | +9.6% | 0.00% | +100.0% |
| Q2 2023 | $64,772 | +29.3% | 27,215 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $50,076 | -3.2% | 27,215 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $51,709 | -10.8% | 27,215 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $58,000 | -36.3% | 27,215 | -15.4% | 0.00% | -50.0% |
| Q2 2022 | $91,000 | -41.3% | 32,178 | -13.4% | 0.00% | -50.0% |
| Q1 2022 | $155,000 | -47.8% | 37,171 | -35.0% | 0.00% | -42.9% |
| Q4 2021 | $297,000 | -53.0% | 57,143 | -40.7% | 0.01% | -58.8% |
| Q3 2021 | $632,000 | -50.4% | 96,424 | -49.7% | 0.02% | -58.5% |
| Q2 2021 | $1,274,000 | +48.3% | 191,820 | +28.0% | 0.04% | +28.1% |
| Q1 2021 | $859,000 | +226.6% | 149,912 | +1773.9% | 0.03% | -15.8% |
| Q4 2018 | $263,000 | – | 8,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,283,966 | $15,166,000 | 1.40% |
| Sio Capital Management, LLC | 591,870 | $3,930,000 | 0.98% |
| TFG Asset Management GP Ltd | 2,500,000 | $16,600,000 | 0.90% |
| Ikarian Capital, LLC | 1,356,048 | $9,004,000 | 0.73% |
| SABBY MANAGEMENT, LLC | 400,050 | $2,656,000 | 0.37% |
| Nantahala Capital Management | 1,793,500 | $11,909,000 | 0.34% |
| Regency Capital Management Inc.\DE | 57,000 | $378,000 | 0.29% |
| Eversept Partners, LP | 473,074 | $3,141,211 | 0.21% |
| MYDA Advisors LLC | 85,000 | $564,000 | 0.14% |
| Henry James International Management Inc. | 54,047 | $359,000 | 0.10% |